Affiliation:
1. Department of Biochemistry and Biophysics, Metabolic Disorders Research Center, Gorgan Faculty of Medicine , Golestan University of Medical Sciences , Gorgan , Golestan province, Iran (Islamic Republic of)
Abstract
Abstract
Background. Subclinical hypothyroidism (sHT) is a condition defined by elevated TSH values with normal levels of free thyroid hormones. Altered metabolic status is one of the consequences of sHT which can affect serum levels of FPG, lipid profile, and nitric oxide which propounds cardiovascular consequences per se. The aim of this study was to determine the possible effects of sHT on nitrite/nitrate levels, as a marker of endothelial performance.
Materials and Methods. 50 females were enrolled in this study, 25 women as control group and 25 women as case group (evaluated two times: before and after levothyroxine therapy). Blood samples were collected and levels of FPG, lipid profile components, and nitric oxide were measured spectrophotometrically. The data were analyzed using SPSS version 18 software.
Results. The levels of lipid profile (except for TG between before and after group, p < 0.05) and nitric oxide did not differ in groups while FPG was significantly higher in case groups in comparison to control group (p < 0.001). Nitric oxide had no correlations with any of variables except for LDL in after treatment group (p < 0.05 and r = 0.397).
Conclusion. Nitric oxide does not have correlation with components of lipid profile (except for LDL) or FPG and has no differences in subclinical hypothyroid patients and control group. Levothyroxine therapy during 2 months cannot alter the levels of nitric oxide in subclinical hypothyroid patients.
Reference44 articles.
1. 1. TADDEI S, CARACCIO N, VIRDIS A, DARDANO A, VERSARI D, GHIADONI L, et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab. 2003; 88: 3731-3737.
2. 2. CANARIS GJ, MANOWITZ NR, MAYOR G, RIDGWAY EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000; 160:526-34.
3. 3. UPADYA UB, SUMA MN, SRINATH KM, PRASHANT A, DODDAMANI P, SHILPA SV, et al. Effect of insulin resistance in assessing the clinical outcome of clinical and subclinical hypothyroid patients. Journal of clinical and diagnostic research: JCDR. 2015; 9(2): OC01-. OC04.
4. 4. MAZAHERI T, SHARIFI F, KAMALI K. Insulin resistance in hypothyroid patients under Levothyroxine therapy: a comparison between those with and without thyroid autoimmunity. Journal of Diabetes & Metabolic Disorders. 2014; 13(1): 103.
5. 5. PEPPA M, KOLIAKI C, NIKOLOPOULOS P, RAPTIS SA. Skeletal muscle insulin resistance in endocrine disease. Journal of Biomedicine and Biotechnology 2010. Article ID 527850.